Abiomed, Inc.ABMDNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+18.4%
5Y CAGR+32.8%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+18.4%/yr
vs +67.3%/yr prior
5Y CAGR
+32.8%/yr
Recent deceleration
Acceleration
-49.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2022$372.69M+62.4%
2021$229.56M-7.9%
2020$249.22M+10.9%
2019$224.81M+43.1%
2018$157.14M+74.3%
2017$90.14M+38.5%
2016$65.10M+127.1%
2015$28.67M+242.8%
2014$8.36M-49.4%
2013$16.54M-